nach oben

Irish Journal of Medical Science (1971 -)

Erschienen in:

09.03.2017 | Original Article

The effect of Rapid Access Prostate Clinics on the outcomes of Gleason 7 prostate cancer: does earlier diagnosis lead to better outcomes?

verfasst von: M. P. Broe, J. C. Forde, M. S. Inder, D. J. Galvin, D. W. Mulvin, D. M. Quinlan

Erschienen in: Irish Journal of Medical Science (1971 -) | Ausgabe 3/2017

Einloggen, um Zugang zu erhalten

Abstract

Introduction

Rapid Access Prostate Clinics (RAPC) were introduced in Ireland by the National Cancer Control Programme bringing about expedited referral pathways and increased detection rates of prostate cancer. Lower Gleason (G) grade at diagnosis due to RAPC has been previously reported but grade at prostatectomy has not been assessed. The aim of this study was to assess the impact of RAPC on the outcomes of patients with G7 disease on radical prostatectomy (RP).

Methods

A retrospective analysis was carried out of all RPs performed over a 9-year period (2006–2014). Outcomes for G7 prostatectomies were compared before and after the introduction of the RAPC, with a further sub-analysis of G4 + 3 versus G3 + 4. The primary outcome was biochemical recurrence (BCR). Other outcomes were adjuvant/salvage radiotherapy, extra prostatic extension, positive surgical margins, seminal vesicle involvement and tumour stage.

Results

In total, 240 RPs were performed with 167 cases graded G7 (70 graded G4 + 3 and 97 graded G3 + 4). Since the introduction of RAPC the proportion of G4 + 3 compared to G3 + 4 has increased from 37.9 to 42%. There was no statistical difference in outcomes for G4 + 3 treated before and after the introduction of RAPC. G4 + 3 was associated with higher rates of BCR (24.4 vs. 0%, p < 0.0001, radiotherapy (41.1 vs. 4.8%, p < 0.0001) and worse histological features than G3 + 4.

Conclusion

Despite the benefits in diagnosis of prostate cancer brought about by RAPC in Ireland, this has not translated to a lower grade for surgically treated patients. There has been no improvement in outcomes especially for higher grade G4 + 3 disease.

Gleason DF (1966) Classification of prostatic carcinomas. Cancer Chemother Rep 50(3):125–128PubMed

Epstein JI, Allsbrook WC Jr, Amin MB, Egevad LL (2005) The 2005 International Society of Urological Pathology (ISUP) consensus conference on Gleason grading of prostatic carcinoma. Am J Surg Pathol 29(9):1228–1242CrossRefPubMed

D’Amico AV, Desjardin A, Chung A, Chen MH, Schultz D, Whittington R et al (1998) Assessment of outcome prediction models for patients with localized prostate carcinoma managed with radical prostatectomy or external beam radiation therapy. Cancer 82(10):1887–1896CrossRefPubMed

Eggener SE, Scardino PT, Walsh PC, Han M, Partin AW, Trock BJ et al (2011) Predicting 15-year prostate cancer specific mortality after radical prostatectomy. J Urol 185(3):869–875CrossRefPubMedPubMedCentral

Helpap B (1998) Prognostic factors of prostatic carcinoma. Der Pathologe 19(1):42–52CrossRefPubMed

Zagars GK, Ayala AG, von Eschenbach AC, Pollack A (1995) The prognostic importance of Gleason grade in prostatic adenocarcinoma: a long-term follow-up study of 648 patients treated with radiation therapy. Int J Radiat Oncol Biol Phys 31(2):237–245CrossRefPubMed

D’Amico AV, Whittington R, Malkowicz SB, Schultz D, Schnall M, Tomaszewski JE et al (1997) Combined modality staging of prostate carcinoma and its utility in predicting pathologic stage and postoperative prostate specific antigen failure. Urology 49(3A Suppl):23–30CrossRefPubMed

Lavery HJ, Droller MJ (2012) Do Gleason patterns 3 and 4 prostate cancer represent separate disease states? J Urol 188(5):1667–1675CrossRefPubMed

Kang DE, Fitzsimons NJ, Presti JC Jr, Kane CJ, Terris MK, Aronson WJ et al (2007) Risk stratification of men with Gleason score 7 to 10 tumors by primary and secondary Gleason score: results from the SEARCH database. Urology 70(2):277–282CrossRefPubMedPubMedCentral

10.

Han M, Partin AW, Pound CR, Epstein JI, Walsh PC (2001) Long-term biochemical disease-free and cancer-specific survival following anatomic radical retropubic prostatectomy. The 15-year Johns Hopkins experience. Urol Clin N Am 28(3):555–565CrossRef

11.

Sakr WA, Tefilli MV, Grignon DJ, Banerjee M, Dey J, Gheiler EL et al (2000) Gleason score 7 prostate cancer: a heterogeneous entity? Correlation with pathologic parameters and disease-free survival. Urology 56(5):730–734CrossRefPubMed

12.

Chan TY, Partin AW, Walsh PC, Epstein JI (2000) Prognostic significance of Gleason score 3 + 4 versus Gleason score 4 + 3 tumor at radical prostatectomy. Urology 56(5):823–827CrossRefPubMed

13.

Alenda O, Ploussard G, Mouracade P, Xylinas E, de la Taille A, Allory Y et al (2011) Impact of the primary Gleason pattern on biochemical recurrence-free survival after radical prostatectomy: a single-center cohort of 1,248 patients with Gleason 7 tumors. World J Urol 29(5):671–676CrossRefPubMed

14.

Rasiah KK, Stricker PD, Haynes AM, Delprado W, Turner JJ, Golovsky D et al (2003) Prognostic significance of Gleason pattern in patients with Gleason score 7 prostate carcinoma. Cancer 98(12):2560–2565CrossRefPubMed

15.

Miyake H, Muramaki M, Furukawa J, Tanaka H, Inoue TA, Fujisawa M (2013) Prognostic significance of primary Gleason pattern in Japanese men with Gleason score 7 prostate cancer treated with radical prostatectomy. Urol Oncol 31(8):1511–1516CrossRefPubMed

16.

Stark JR, Perner S, Stampfer MJ, Sinnott JA, Finn S, Eisenstein AS et al (2009) Gleason score and lethal prostate cancer: does 3 + 4 = 4 + 3? J Clin Oncol 27(21):3459–3464CrossRefPubMedPubMedCentral

17.

Wright JL, Salinas CA, Lin DW, Kolb S, Koopmeiners J, Feng Z et al (2009) Prostate cancer specific mortality and Gleason 7 disease differences in prostate cancer outcomes between cases with Gleason 4 + 3 and Gleason 3 + 4 tumors in a population based cohort. J Urol 182(6):2702–2707CrossRefPubMedPubMedCentral

18.

Chandra RA, Chen MH, Zhang D, Loffredo M, D’Amico AV (2015) Age, comorbidity, and the risk of prostate cancer-specific mortality in men with biopsy Gleason score 4 + 3: implications on patient selection for multiparametric MRI. Clin Genitourin Cancer 13(4):400–405CrossRefPubMed

19.

Health Service Executive (2006) National Cancer Control Strategy Ireland. http://www.hse.ie/eng/services/Publications/HealthProtection/Public_Health_/National_Cancer_Control_Strategy.pdf. Accessed 15 Sept 2015

20.

Forde JC, O’Connor KM, Casey L, O’Brien M, Bowen S, Casey RG et al (2011) A rapid access diagnostic clinic for prostate cancer: the experience after one year. Ir J Med Sci 180(2):505–508CrossRefPubMed

21.

Oon SF, Cullen IM, Moran D, Bolton EM, McDermott T, Grainger R et al (2014) The effect of a Rapid Access Prostate Cancer Clinic on prostate cancer patient and disease characteristics, primary treatment and surgical workload. Ir J Med Sci 183(2):241–247CrossRefPubMed

22.

O’Kelly F, Thomas AZ, Murray D, Lee P, O’Carroll RF, Nicholson P et al (2013) Emerging evidence for Gleason grade migration and distance impact in prostate cancer? An analysis of the rapid access prostate clinic in a tertiary referral center: St. Vincent’s University Hospital, Dublin (2009–2011). Ir J Med Sci 182(3):487–491CrossRefPubMed

23.

Daly T, Hickey BE, Lehman M, Francis DP, See AM (2011) Adjuvant radiotherapy following radical prostatectomy for prostate cancer. Cochrane Database Syst Rev 12:Cd007234

24.

Novara G, Ficarra V, Mocellin S, Ahlering TE, Carroll PR, Graefen M et al (2012) Systematic review and meta-analysis of studies reporting oncologic outcome after robot-assisted radical prostatectomy. Eur Urol 62(3):382–404CrossRefPubMed

25.

Wolff RF, Ryder S, Bossi A, Briganti A, Crook J, Henry A et al (2015) A systematic review of randomised controlled trials of radiotherapy for localised prostate cancer. Eur J Cancer (Oxf, Engl: 1990) 51(16):2345–2367CrossRef

26.

Winters BR, Wright JL, Holt SK, Lin DW, Ellis WJ, Dalkin BL et al (2016) Extreme gleason upgrading from biopsy to radical prostatectomy: a population-based analysis. Urology 96:148–155CrossRefPubMed

27.

Corcoran NM, Hong MK, Casey RG, Hurtado-Coll A, Peters J, Harewood L et al (2011) Upgrade in Gleason score between prostate biopsies and pathology following radical prostatectomy significantly impacts upon the risk of biochemical recurrence. BJU Int 108(8 Pt 2):E202–E210CrossRefPubMed

28.

Hattab EM, Koch MO, Eble JN, Lin H, Cheng L (2006) Tertiary Gleason pattern 5 is a powerful predictor of biochemical relapse in patients with Gleason score 7 prostatic adenocarcinoma. J Urol. 175(5):1695–1699 (discussion 9) CrossRefPubMed

29.

Whittemore DE, Hick EJ, Carter MR, Moul JW, Miranda-Sousa AJ, Sexton WJ (2008) Significance of tertiary Gleason pattern 5 in Gleason score 7 radical prostatectomy specimens. J Urol 179(2):516–522 (discussion 22) CrossRefPubMed

30.

Adam M, Hannah A, Budaus L, Steuber T, Salomon G, Michl U et al (2014) A tertiary Gleason pattern in the prostatectomy specimen and its association with adverse outcome after radical prostatectomy. J Urol 192(1):97–101CrossRefPubMed

31.

van Oort IM, Schout BM, Kiemeney LA, Hulsbergen CA, Witjes JA (2005) Does the tertiary Gleason pattern influence the PSA progression-free interval after retropubic radical prostatectomy for organ-confined prostate cancer? Eur Urol 48(4):572–576CrossRefPubMed

32.

Yossepowitch O, Briganti A, Eastham JA, Epstein J, Graefen M, Montironi R et al (2014) Positive surgical margins after radical prostatectomy: a systematic review and contemporary update. Eur Urol 65(2):303–313CrossRefPubMed

33.

Meeks JJ, Eastham JA (2013) Radical prostatectomy: positive surgical margins matter. Urol Oncol 31(7):974–979CrossRefPubMed

34.

Stephenson AJ, Scardino PT, Eastham JA, Bianco FJ Jr, Dotan ZA, DiBlasio CJ et al (2005) Postoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy. J Clin Oncol 23(28):7005–7012CrossRefPubMedPubMedCentral

35.

Makarov DV, Sanderson H, Partin AW, Epstein JI (2002) Gleason score 7 prostate cancer on needle biopsy: is the prognostic difference in Gleason scores 4 + 3 and 3 + 4 independent of the number of involved cores? J Urol 167(6):2440–2442CrossRefPubMed

Titel: The effect of Rapid Access Prostate Clinics on the outcomes of Gleason 7 prostate cancer: does earlier diagnosis lead to better outcomes?
verfasst von: M. P. Broe
J. C. Forde
M. S. Inder
D. J. Galvin
D. W. Mulvin
D. M. Quinlan
Publikationsdatum: 09.03.2017
Verlag: Springer London
Erschienen in: Irish Journal of Medical Science (1971 -) / Ausgabe 3/2017
Print ISSN: 0021-1265
Elektronische ISSN: 1863-4362
DOI: https://doi.org/10.1007/s11845-017-1583-2

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren.

Aquatherapie bei Fibromyalgie wirksamer als Trockenübungen

03.05.2024 Fibromyalgiesyndrom Nachrichten

Bewegungs-, Dehnungs- und Entspannungsübungen im Wasser lindern die Beschwerden von Patientinnen mit Fibromyalgie besser als das Üben auf trockenem Land. Das geht aus einer spanisch-brasilianischen Vergleichsstudie hervor.

Wo hapert es noch bei der Umsetzung der POMGAT-Leitlinie?

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Das Risiko für Vorhofflimmern in der Bevölkerung steigt

02.05.2024 Vorhofflimmern Nachrichten

Das Risiko, im Lauf des Lebens an Vorhofflimmern zu erkranken, ist in den vergangenen 20 Jahren gestiegen: Laut dänischen Zahlen wird es drei von zehn Personen treffen. Das hat Folgen weit über die Schlaganfallgefährdung hinaus.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar "Chronische Unterbauch- und Viszeralschmerzen in der Praxis managen"

Springer Medizin

Abstract

Introduction

Methods

Results

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2017

An international assessment of trainee experience, confidence, and comfort in operative vaginal delivery

A review of a GP registrar-run mobile health clinic for homeless people

Optic neuritis secondary to antiandrogen therapy

The duration of gonadotropin stimulation does not alter the clinical pregnancy rate in IVF or ICSI cycles

Circulating levels of fibroblast growth factor 21 in early-stage diabetic kidney disease

In recognition of Ireland’s medical scientists—Arnold Hill, Mark Lawler, Ian Young and Kingston Mills